SCHEMBL7370959

SCHEMBL7370959

COCC[C@H]1C(=O)N(Cc2ccc3c(N)ncnc3c2)CCN1C(=O)C=Cc1cc(Br)cs1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.42
KCNA3 P22001 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772491 0.93 F10 (0.43) F10KCNA3
SCHEMBL1652567 0.93 F10 (0.43) F10KCNA3
SCHEMBL1384564 0.92 F10 (0.42) F10
SCHEMBL1384567 0.92 F10 (0.42) F10
SCHEMBL4390879 0.92 F10 (0.44) F10
SCHEMBL1652670 0.92 F10 (0.44) F10
SCHEMBL4388866 0.90 F10 (0.45) F10
SCHEMBL1654345 0.90 F10 (0.45) F10
SCHEMBL4390090 0.88 F10 (0.46) F10
SCHEMBL4390087 0.88 F10 (0.46) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051176-A4 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARM PROD INC (US) 2002-06-12 EP disclosed
EP-1051176-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP disclosed
WO-1999037304-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-07-29 WO disclosed